Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
2.04 AUD | +3.03% |
|
+21.07% | +213.85% |
Jun. 27 | EZZ Life Science Sees AU$19 Million in Cash by End of Q4 | MT |
Jun. 25 | EZZ Life Science Expanding to US Market After FDA Approval of Food Supplement Products; Shares Hit All-Time High | MT |
Business Summary
Sales per Business
AUD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Company Owned
87.6
%
| 8 | 54.2 % | 33 | 87.6 % | +299.83% |
Brought in Lines
12.4
%
| 7 | 45.8 % | 5 | 12.4 % | -33.14% |
Sales per region
AUD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
China
72.1
%
| 4 | 29.0 % | 27 | 72.1 % | +516.15% |
Australia and New Zealand
26.3
%
| 9 | 62.8 % | 10 | 26.3 % | +3.45% |
Other Countries/Regions
1.6
%
| 1 | 8.2 % | 1 | 1.6 % | -52.75% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Qi Zhou Qin
FOU | Founder | - | 15-09-21 |
Anthony Guarna
DFI | Director of Finance/CFO | - | - |
Natalie Climo
SEC | Corporate Secretary | - | 20-07-07 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Glenn Cross
CHM | Chairman | - | 21-11-29 |
Ivan Oshry
BRD | Director/Board Member | - | 20-10-26 |
Qi Zhou Qin
FOU | Founder | - | 15-09-21 |
Hao Huang
BRD | Director/Board Member | - | 20-10-26 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 42,705,000 | 11,883,047 ( 27.83 %) | 0 | 27.83 % |
Company contact information
![address EZZ Life Science Holdings Limited(EZZ)](https://cdn.zonebourse.com/static/address/119962344.png)
Sector
Sales per Business
Sales per region
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+204.62% | 56.79M | |
+60.25% | 846B | |
+38.56% | 628B | |
-4.49% | 360B | |
+18.30% | 322B | |
+9.64% | 297B | |
+14.15% | 240B | |
+3.11% | 224B | |
+16.98% | 223B | |
+12.87% | 173B |
- Stock Market
- Equities
- EZZ Stock
- Company EZZ Life Science Holdings Limited